During the past decade, Kaluga Regional Clinical Oncology Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 1 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaluga Regional Clinical Oncology Center" #1 sponsor was "Pfizer" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored, "Mabscale, LLC" with 1 trials sponsored and "MelanomaPRO, Russia" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaluga Regional Clinical Oncology Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Crocus Medical B.V." with 1 trials as a collaborator, "Kaluga Regional Clinical Oncology Center" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Multidisciplinary medical holding SM-Clinic" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Kaluga Regional Clinical Oncology Center" are "Non-Small Cell Lung Cancer" (2 trials), "BRAF V600 Mutation" (1 trials), "Breast Neoplasms" (1 trials), "Cancer" (1 trials) and "Cutaneous Melanoma, Stage IV" (1 trials). Many other conditions were trialed in "Kaluga Regional Clinical Oncology Center" in a lesser frequency.

Most popular intervention types in "Kaluga Regional Clinical Oncology Center" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Bevacizumab" (2 trials), "Paclitaxel" (2 trials), "5-FU" (1 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaluga Regional Clinical Oncology Center" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Kaluga Regional Clinical Oncology Center". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kaluga Regional Clinical Oncology Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaluga Regional Clinical Oncology Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Kaluga Regional Clinical Oncology Center has several departments that took part in Clinical trials: "Kaluga Regional Oncology Center" - 2 trials